Abstract Submission

Call for abstracts!

Participants interested in presenting papers at the Oral and e-Poster sessions are invited to submit their abstracts. Submitted abstracts will be reviewed by the Abstract Reviewing Committee. All accepted abstracts will be collected into the official Book of Abstracts that will be published as an online supplement of the Journal of the IMS, Climacteric.
The highest ranked abstracts among those submitted for oral presentation may be considered by the Scientific Program Committee for presentation during Symposia instead of Oral Communication Sessions.

  • Deadline for abstract submissions: 30 Jan 2018
  • Presenting authors will be notified whether their abstract has been accepted by February 27th 2018.
  • Authors whose abstracts have been accepted must register for the Congress and pay the registration fee by March 20th, 2018. Failure to do so will result in exclusion from the Scientific Program and the Book of Abstracts.

Abstract structure

The abstract cannot be longer than 2000 characters and must be plain text: it is not possible to include tables and images, but you may insert data in the text of the abstract. Abstracts for free communications and posters should be divided into: ObjectiveMethods Results Conclusions

Is my abstract approved?
Check it now!

The abstract submission is closed
Only abstracts agreed with the Scientific Committee can be submitted

To submit an abstract:

1. Create your free account on this website;
2. Once in your personal page click on the Abstract submission button

Are you under 40? See the rules for the Greenblatt prize.
left to send an abstract.

The abstract submission for Posters and Oral Communications is closed.

All accepted abstracts will be printed in a supplement to the IMS journal, Climacteric

The IMS Robert Greenblatt Prizes

Robert B. Greenblatt, co-founder and first President of the International Menopause Society, originally conceived the idea of awarding prizes to the two junior researchers who present the best papers in the field of the menopause. There are two prizes each of 2500GBP, for the best papers presented, in either basic research or clinical work.

  • Award winners must be under 40 years of age or in training at the time of the Congress.
  • They must have been the sole or principal researcher in the paper presented.
  • Entrants for the Greenblatt prizes must submit their work in abstract form and tick the "Greenblatt prize" checkbox.

 The IMS Awards Subcommittee will review the abstracts and select
a shortlist of six candidates (three for clinical works and three for basic research). Shortlisted candidates will be invited to present their papers to the jury at a special oral session on the first day of Congress. The final vote will be taken and the names of the award winners announced during the opening ceremony.

The abstract submission is closed.


  • 1. General menopause including
    • Epidemiology, basic science
      and clinical research
    • Diagnosis of menopause
    • Hormone and non-hormonal therapy
    • Premature ovarian insufficiency
    • The menopause after cancer
    • Other topics related to the menopause
  • 2. Hormones and hormone action
    • Hormones and hormone receptor
      signaling mechanisms
    • Biological actions of sex steroids
      Selective hormone receptor modulators
    • Novel treatments and regimens
  • 3. Hormones and the metabolism including
    • Obesity
    • Metabolic syndrome
    • Insulin resistance, diabetes and dyslipidemia
    • Other topics related to hormones and the metabolism
  • 4. Sexual function including
    • Epidemiology,
    • basic science
      and clinical research
    • Treatment options – psychological
      and medical approaches

  • 5. Menopause and cardiovascular system including
    • Epidemiology, basic science and clinical research
    • Hormones and coronary heart disease
    • Hormones and thrombosis
    • Hormones and cerebrovascular disease
    • Other cardiovascular topics
  • 6. Menopause and the brain including
    • Neurosteroids and actions
    • Cognitive function
    • Sleep and sleep disorders
    • Alzheimer’s disease and other neurodegenerative disorders
  • 7. Mood and mental disorders including
    • Epidemiology, basic science and clinical research
    • Hormonal and non-hormonal treatment of mood disorders (including perimenopausal and premenstrual depression)
    • Schizophrenia and other mental disorders
  • 8. Musculoskeletal health including
    • Bone loss and osteoporosis
    • Sarcopenia
    • Pharmacological and non-pharmacological fracture prevention

  • 9. Breast health including
    • Breast and breast cancer biology
    • Breast cancer epidemiology
    • Hormone therapy and breast cancer
    • Breast cancer screening and diagnosis
    • Tolerance and aromatase inhibitor-related side-effects
    • Adjuvant bisphosphonates
    • Other topics related to breast and breast cancer
  • 10. Gynecology including
    • Abnormal uterine bleeding
    • Management of fibroids – medical and surgical
    • Endometriosis (in perimenopause and consequences of surgery)
    • PCOS – implications for menopause
    • Endometrial hyperplasia and cancer
    • Vulval and vaginal conditions – VVA/GSM and other disorders
    • Diagnostic gynecology
    • Urogynecology – including incontinence and prolapse
  • 11. Other oncology including
    • Hormones and non-gynecological cancer
    • Screening, diagnosis and treatment of women
    • Treatment consequences in relation to the menopause
    • Novel non-hormonal treatment regimens